INS and Hypoglycemia: However, high systemic doses would be needed to achieve functionally effective insulin concentrations in the brain, causing strong peripheral side effects such as hypoglycemia and induction and/or exacerbation of peripheral insulin resistance (Benedict et al., 2011).